KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Pacific Biosciences Of California (PACB) over the last 16 years, with Q3 2025 value amounting to $767.1 million.

  • Pacific Biosciences Of California's Total Non-Current Liabilities fell 2142.95% to $767.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $767.1 million, marking a year-over-year decrease of 2142.95%. This contributed to the annual value of $735.2 million for FY2024, which is 2828.89% down from last year.
  • According to the latest figures from Q3 2025, Pacific Biosciences Of California's Total Non-Current Liabilities is $767.1 million, which was down 2142.95% from $764.0 million recorded in Q2 2025.
  • In the past 5 years, Pacific Biosciences Of California's Total Non-Current Liabilities registered a high of $1.2 billion during Q4 2022, and its lowest value of $735.2 million during Q4 2024.
  • For the 5-year period, Pacific Biosciences Of California's Total Non-Current Liabilities averaged around $974.3 million, with its median value being $1.0 billion (2023).
  • Per our database at Business Quant, Pacific Biosciences Of California's Total Non-Current Liabilities skyrocketed by 124590.48% in 2021 and then plummeted by 2828.89% in 2024.
  • Over the past 5 years, Pacific Biosciences Of California's Total Non-Current Liabilities (Quarter) stood at $1.0 billion in 2021, then grew by 14.97% to $1.2 billion in 2022, then decreased by 14.77% to $1.0 billion in 2023, then decreased by 28.29% to $735.2 million in 2024, then rose by 4.34% to $767.1 million in 2025.
  • Its last three reported values are $767.1 million in Q3 2025, $764.0 million for Q2 2025, and $769.2 million during Q1 2025.